> ## Content Index
> Fetch the complete content index at: https://www.journal.ninthheaven.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Lipopolysaccharide Biosynthesis and Membrane Mechanics: A Hypothesis for TLR4 Activation
- URL: https://www.journal.ninthheaven.co/dev-bio-with-isaac/inflammation-1-lps/
- Published: 2026-10-31T10:09:48.000Z
- Updated: 2026-10-31T10:09:48.000Z
- Description: Inflammation is a coordinated multicellular response to tissue injury. Using LPS as a model for initiation, this essay introduces the molecular structure of LPS and a hypothesis for TLR4 activation, laying the groundwork for upcoming papers in this series.
- Author: Isaac Deng
- Tags: Developmental Biology with Isaac, Academia, Newsletters

Microbial infections have historically been a leading cause of human mortality, with natural products providing the earliest antimicrobial compounds ([Bassett et al., 1980](#fn-bassett-1980)). Modern antimicrobials and greater understanding of the molecular basis of microbial pathogenesis have since transformed infectious disease management ([Aminov, 2010](#fn-aminov-2010); [Souza et al., 2025](#fn-souza-2025)). A key milestone in pathogenesis research was identifying the specific microbial components that elicit host immune responses. Notably, the ability of bacterial lipopolysaccharide (LPS), a major outer membrane constituent of Gram-negative bacteria, to experimentally induce sepsis-like syndromes established its potency as an inflammatory stimulus (Lowry, 1970).

Today, LPS is recognised as a prototypical pathogen-associated molecular pattern (PAMP) detected by the TLR4–MD-2 receptor complex, with CD14 facilitating ligand delivery ([Janeway, 1989](#fn-janeway-1989); [Shimazu et al., 1999](#fn-shimazu-1999); [Beutler, 2000](#fn-beutler-2000); [Miyake, 2000](#fn-miyake-2000); [Nagai et al., 2002](#fn-nagai-2002); [Akashi et al., 2003](#fn-akashi-2003)). This recognition triggers signalling cascades that drive inflammatory gene expression and innate immune activation. In this review, I examine the molecular structure and biosynthesis of LPS before proposing a modified mechanism for how it induces host inflammation. Downstream signalling pathways, immune activation mechanisms, and a detailed evaluation of this proposal are reserved for a subsequent essay.

LPS comprises three structurally distinct domains: the hydrophobic lipid A moiety, which binds directly to TLR4; a core oligosaccharide divided into inner and outer regions; and a highly variable, surface-exposed O-antigen. The biosynthesis of LPS is spatially segregated with the hydrophobic lipid A backbone and core oligosaccharides being sequentially assembled at the cytoplasmic leaflet of the inner membrane, after which the complex is translocated across the periplasm to undergo final glycan modification and assembly at the outer membrane ([Tang et al., 2025](#fn-tang-2025)). 

## Lipid A is synthesised on the cytoplasmic face of the bacterial inner membrane, flipped, and modified on the periplasmic face to form mature LPS

Although lipid A structures vary across diverse Gram-negative bacteria, their biosynthesis is governed by a highly conserved and strictly compartmentalised enzymatic pathway. Intriguingly, both lipid A and peptidoglycan biosynthesis utilise the common precursor UDP-N-acetylglucosamine (UDP-GlcNAc), potentially suggesting a centralised metabolic checkpoint for cell wall synthesis ([Dowhan W, 2011](#fn-dowhan-2011)). Moreover, the fact that these distinct glycan-based PAMPs engage distinct PRRs suggests a conserved carbohydrate-based recognition system that may be due to the ubiquity of these compounds or bulk structural kinetics and the physical properties these macromolecules impose upon the host cell boundaries (this, to my knowledge, is an uninvestigated area). A detailed discussion of these host-pathogen interactions lies beyond the scope of this review, which focuses on the foundational enzymatic assembly of these structures. My hope is to eventually return and review this in more depth.

Lipid A biosynthesis is a nine-enzyme pathway, best characterised in Escherichia coli bacteria. It initiates with a direct acylation reaction catalysed by the soluble acyltransferase LpxA (see Figure 1) ([Dowhan W, 2011](#fn-dowhan-2011)). Given its thermodynamic unfavourability and highly reversible nature, this initial step does not dictate metabolic flux, nor does LpxA act as a rate-limiting enzyme ([Anderson, M. S., & Raetz, C. R., 1987](#fn-anderson-1987)). Instead, the pathway relies on immediate downstream consumption to pull this initial reaction forward. The subsequent deacetylation reaction catalysed by LpxC represents the first committed step of lipid A biosynthesis. LpxC (EnvA) is a zinc metalloamidase that, remarkably, shares no structural or sequence homology with mammalian proteins, yet remains highly conserved across Gram-negative bacteria. While LpxC inhibitors are actively being investigated as novel antibiotic candidates, rational drug optimisation has historically been complicated by structural divergences; specifically, the fact that the enzyme's dynamic conformational states in solution differ from those captured in rigid crystal structures ([Kumar Pal, S., 2023](#fn-kumar-pal-2023)). 

Following deacetylation, a second fatty acid chain is incorporated by LpxD, which catalyses the transfer of another *(R)*\-3-hydroxymyristoyl group from acyl-ACP onto the newly exposed, free amino group at the 2-position of the glucosamine ring, generating UDP-2,3-diacyl-GlcN (see figure). This step completes the symmetrical acyl profile of the monomeric precursor, positioning the molecule for a critical structural bifurcation that splits the precursor pool into two distinct, highly reactive halves ([Babinski, K. J., et al., 2002](#fn-babinski-2002)).

![Diagram of the Raetz pathway showing the enzymatic steps of lipid A biosynthesis.](https://www.journal.ninthheaven.co/content/images/2026/10/data-src-image-7539b18d-6f06-48b3-9e68-54d53a137aa0.png)

Figure 1: The Raetz pathway for Lipid A biosynthesis. From [Hummels K. R. (2025)](#fn-hummels-2025)

To prepare for structural condensation, a fraction of the UDP-2,3-diacyl-GlcN pool must undergo pyrophosphate cleavage. In most Gram-negative bacteria, this is done through LpxH (or structurally distinct homologues like LpxI in alternative taxa). These enzymes hydrolyse the pyrophosphate bond of UDP-2,3-diacyl-GlcN, thus selectively removing the UMP moiety and leaving a terminal 1-phosphate on the sugar ring to generate 2,3-diacyl-GlcN-1-phosphate (also known as Lipid X). By so doing, a potent nucleophile essential for assembling the core lipid disaccharide architecture is yielded. Now the assembly of the foundational lipid A disaccharide backbone can occur. LpxB on the cytoplasmic face of the inner membrane condenses one molecule of UDP-2,3-diacyl-GlcN (the glycosyl donor) with one molecule of 2,3-diacyl-GlcN-1-phosphate (the nucleophilic glycosyl acceptor). Thus, the segments join via a β-1',6-glycosidic linkage, liberating UDP and synthesising the symmetric, tetra-acylated intermediate: β-1',6-linked disaccharide 1-phosphate (Figure 1) ([Raetz, C. R., et al., 2006](#fn-raetz-2006)).

![Structure of E. coli lipid A, showing its glucosamine backbone, two phosphate groups, and six fatty acid chains.](https://www.journal.ninthheaven.co/content/images/2026/10/data-src-image-7a84cc90-48d8-4e8c-8a98-71f2034a8ec9.png)

Figure 2: Structure of E. coli lipid A. E. coli lipid A is a hexa-acylated glucosamine disaccharide. The figure shows a β(1-6)-linked glucosamine disaccharide backbone (brown) phosphorylated with two phosphate groups (green). This backbone connects to the core region via a hydroxyl group (yellow) located on the distal glucosamine unit. Branching off the central sugar frame are six fatty acid tails divided into primary and secondary categories. The four primary acyl chains are all hydroxymyristates that link directly to the glucosamine rings. The primary chains also have secondary branches (red), one myristate and one laurate, which esterify to the free hydroxyl groups of the primary tails rather than attaching to the sugar backbone itself. From [Steimle, A., et al., 2016](#fn-steimle-2016)

To balance the charge profile of the developing hydrophobic core, the newly formed disaccharide is rapidly modified by the integral inner membrane kinase LpxL. Utilising ATP as a phosphate donor, LpxK specifically phosphorylates the 4'-hydroxyl group of the distal glucosamine ring on the disaccharide backbone. This reaction introduces the crucial 4'-phosphate group, symmetry-matching the existing 1-phosphate on the proximal ring to form the symmetrical, tetra-acylated, bis-phosphorylated intermediate widely known as lipid IVA ([Raetz, C. R., 2006](#fn-raetz-2006)).

In the classical E. coli paradigm, lipid IVA serves as the mandatory structural scaffold for the addition of the core oligosaccharide through Kdo transferase WaaA. WaaA sequentially transfers two 3-deoxy-D-*manno*\-oct-2-ulosonic acid (Kdo) sugar residues from CMP-Kdo donors onto the 6'-position of the distal glucosamine ring. This step crucially forms an absolute structural checkpoint as evinced by the fact that in most wild-type organisms the downstream late acyltransferases cannot recognise the lipid backbone unless it is appropriately glycosylated with this Kdo marker. Finally, the late acyltransferases LpxL and LpxM mediate the formation of the canonical hexa-acylated Kdo2-lipid A ([Raetz, C. R., 2006](#fn-raetz-2006)).

## Gram-negative bacteria, such as Helicobacter pylori, use specific glycosyltransferases to extend their core oligosaccharide backbone

While Kdo2-lipid A undergoes immediate MsbA-mediated transport in minimalist species (such as Haemophilus, Bordetella, or mutant E. coli), most Gram-negative bacteria sequentially extend this core oligosaccharide (OS) via peripheral membrane glycosyltransferases (Figure 3). This extension (aka core oligosaccharide assembly) is initiated on the cytoplasmic face of the inner membrane by WaaA, which transfers two Kdo residues onto the lipid A scaffold. Then there is even more subsequent extension by the glycosyltransferases WaaC and WaaF, which attach the conserved inner-core heptose sugars. Downstream outer-core Waa enzymes (such as WaaG) then append species-specific hexoses to complete the rough lipopolysaccharide structure. Once assembled, the entire lipid A–core complex is translocated across the inner membrane to the periplasm by the MsbA ABC transporter. Finally, the periplasmic WaaL ligase completes the pathway by covalently fusing the finished core oligosaccharide to the arriving O-antigen chain ([Tang et al., 2025](#fn-tang-2025)).

![Comparison of Kdo residues attached to lipid A in E. coli, Chlamydia trachomatis, and Haemophilus influenzae.](https://www.journal.ninthheaven.co/content/images/2026/10/data-src-image-58df3513-0fb4-400e-94e3-6b1c1e53acac.png)

Figure 3: Variation in lipid A structure. The WaaA glycosyltransferase dictates how many Kdo residues anchor the core oligosaccharide to lipid A. E. coli uses a bifunctional WaaA to attach two Kdo residues (yellow). On the other hand, Chlamydia trachomatis features a trifunctional WaaA that builds a highly unique three-Kdo anchor. Haemophilus influenzae expresses a monofunctional WaaA restricted to adding a single Kdo residue. Thus, bacteria like H. influenzae (termed minimalist species) rely on heavy modification with phosphate or ethanolamine groups to resist host immune defences.

Helicobacter pylori is a primary aetiological agent of peptic ulcers and gastric cancer. While its prevalence has declined in developed nations over recent decades, the pathogen remains a major driver of morbidity in developing countries. To colonise the hostile, highly acidic gastric niche, H. pylori relies on a multifaceted survival strategy. Crucial to this fitness is the structural integrity of its cell envelope. Targeted mutagenesis of core oligosaccharide biosynthetic genes induces a morphological transition from the characteristic spiral shape to an unviable, round coccoid form (Tang X., et al, 2025).

Side note: Kdo synthesis is a prerequisite for the growth of most Gram-negative bacteria but can be bypassed in E. coli and Salmonella following msbA overexpression. It is no surprise, therefore, that MsbA has also emerged as a potential antibiotic target ([Reynolds, C. M., & Raetz, C. R., 2009](#fn-reynolds-2009)).

## The O-antigen component of LPS is initially independently assembled as an Und-PP-linked saccharide before it is ligated to the lipid A moiety

O-antigens are highly polymorphic glycopolymers comprising repeating saccharide units that exhibit vast structural and chemical diversity. Functionally, these surface-exposed antigens serve as critical virulence factors, shielding pathogens from phagocytosis and serum complement-mediated killing while facilitating host cell entry, intracellular survival, and biofilm formation. Given this extensive structural heterogeneity, a comprehensive review of O-antigen variations would be beyond the scope of this paper (I refer keen readers to [Samuel and Reeves, 2003](#fn-samuel-2003), for an in-depth review). Here, I will only discuss the conserved biophysical process of O-antigen ligation to the lipid A-core.

![WaaL-mediated O-antigen ligation, with a reaction schematic, cryo-EM map, membrane topology, and enzyme structures.](https://www.journal.ninthheaven.co/content/images/2026/10/data-src-image-bc2ad76d-879e-4e19-8259-6e479cbee4ad.png)

Figure 4: The atomic structure and chemical mechanism of WaaL. A: WaaL transfers a long sugar chain (the O-antigen) from its lipid carrier molecule (Und-PP) and links it to the lipid A core oligosaccharide to form mature LPS, which then allows the emptied Und-PP carrier to be recycled (yellow). B: Cryo-EM map of an attached stabilising antibody fragment (shown in grey) and the WaaL enzyme itself in a rainbow gradient running from its blue N-terminus to its red C-terminus. C: topological architectural blueprint mapping how the protein weaves through the inner membrane 12 times. Note the massive functional loop located between transmembrane helices 9 and 10 that extends into the periplasmic space where the actual chemical linking happens. D: Two-angle view of WaaL at high resolution. The dual orientation shows how the helices bundle together to form a protective cavity inside the cell membrane. The gold sticks represent the Und-PP lipid carrier, pinpointing the exact active site pocket where WaaL binds its target to build the bacterial outer coat. From [Ashraf, K. U., et al., 2022](#fn-ashraf-2022)

The O-antigen is independently assembled on the cytoplasmic face of the inner membrane as an undecaprenyl pyrophosphate (Und-PP)-linked saccharide before being flipped across the bilayer (another ABC is involved in this, the wzm-wzt). The subsequent covalent attachment of the O-antigen to the lipid A-core occurs exclusively on the periplasmic side of the inner membrane, mediated by the O-antigen ligase WaaL (Figure 4). WaaL is an integral membrane protein comprising multiple transmembrane helices interspersed with functionally critical periplasmic loops. Despite catalysing the formation of a glycosidic bond, WaaL belongs to the GT-C superfamily of glycosyltransferases and fundamentally diverges from classical GT-A or GT-B glycosyltransferases that utilise soluble nucleotide-sugar substrates. While WaaL displays strict structural specificity for its lipid A-core acceptor, it exhibits highly relaxed substrate specificity toward its Und-PP-linked carbohydrate donors. Consequently, Und-PP-linked sugars originating from diverse metabolic pathways (including those expressed heterologously via recombinant methods) can serve as viable substrates for a single strain’s WaaL machinery ([Ashraf, K. U., et al., 2022](#fn-ashraf-2022)).

So far, I have presented a narrative on the structural determinants of LPS function. I will now pivot towards a discussion of LPS function and, more importantly, its ability to activate inflammatory signalling cascades beyond the PAMP/PRR framework. I will complete this discussion in my next paper on Toll receptors.

## Central hypothesis: Do membrane mechanics determine TLR4 activation?

While LPS is physiologically chaperoned by LBP and CD14 during its delivery to MD-2, its amphiphilic structure also provides the capacity to interact with host phospholipid bilayers ([Adams et al., 2014](#fn-adams-2014)). If incorporated into the exofacial leaflet, the bulky, highly charged lipid A domain could introduce local packing asymmetry, perturb lateral pressure profiles and alter the spontaneous curvature of the bilayer. Such perturbations may influence the organisation and stability of cholesterol-rich membrane microdomains. Indeed, recent evidence demonstrates that LPS-induced remodelling of sphingomyelin-cholesterol interactions regulates TLR4 redistribution and inflammatory activation ([Antón-Barros et al., 2026](#fn-anton-barros-2026)). Conversely, TLR4 activation itself modifies macrophage membrane fluidity through altered sterol metabolism, including the accumulation of lanosterol ([Araldi et al., 2017](#fn-araldi-2017)). These observations raise the possibility of a bidirectional relationship between membrane organisation and TLR4 activity. Thus, one may ask, could TLR4 function as a sensor of membrane perturbation, with its activation reflecting not only ligand recognition but also the biophysical state of the host membrane?

LBP-facilitated transfer of LPS to HDL provides a further consideration. Given the capacity of LPS to associate with host membranes, HDL-mediated sequestration may restrict the membrane perturbations proposed here to influence receptor activity ([Wurfel et al., 1994](#fn-wurfel-1994); [Wurfel et al., 1995](#fn-wurfel-1995)). Whether this biophysical effect contributes to the attenuation of endotoxin-induced inflammation remains to be established. However, this proposal offers an interesting point of investigation: if, indeed, HDL sequestration limits LPS-induced membrane perturbation, either by reducing CD14-mediated delivery or limiting spontaneous bilayer incorporation, its kinetics should correspond to the decline in membrane perturbation and TLR4 activation during endotoxaemia.

"Das ist ja toll!" is what he said…

## References

1. Adams, P. G., et al. (2014). Lipopolysaccharide-induced dynamic lipid membrane reorganization: Tubules, perforations, and stacks. *Biophysical Journal, 106*(11), 2395–2407\. [https://doi.org/10.1016/j.bpj.2014.04.016](https://doi.org/10.1016/j.bpj.2014.04.016?ref=journal.ninthheaven.co)
2. Akashi, S., Saitoh, S., Wakabayashi, Y., Kikuchi, T., Takamura, N., Nagai, Y., Kusumoto, Y., Fukase, K., Kusumoto, S., Adachi, Y., Kosugi, A., & Miyake, K. (2003). Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: Higher affinity than that with MD-2 or CD14\. *The Journal of Experimental Medicine, 198*(7), 1035–1042\. [https://doi.org/10.1084/jem.20031076](https://doi.org/10.1084/jem.20031076?ref=journal.ninthheaven.co)
3. Aminov, R. I. (2010). A brief history of the antibiotic era: Lessons learned and challenges for the future. *Frontiers in Microbiology, 1*, Article 134\. [https://doi.org/10.3389/fmicb.2010.00134](https://doi.org/10.3389/fmicb.2010.00134?ref=journal.ninthheaven.co)
4. Anderson, M. S., & Raetz, C. R. (1987). Biosynthesis of lipid A precursors in *Escherichia coli*. A cytoplasmic acyltransferase that converts UDP-N-acetylglucosamine to UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine. *The Journal of Biological Chemistry, 262*(11), 5159–5169.
5. Antón-Barros, C., et al. (2026). A sphingomyelin-cholesterol complex regulates TLR4 activation in microglia. *bioRxiv* \[Preprint; not peer reviewed\]. [https://doi.org/10.64898/2026.09.10.750647](https://doi.org/10.64898/2026.09.10.750647?ref=journal.ninthheaven.co)
6. Araldi, E., et al. (2017). Lanosterol modulates TLR4-mediated innate immune responses in macrophages. *Cell Reports, 19*(13), 2743–2755\. [https://doi.org/10.1016/j.celrep.2017.05.093](https://doi.org/10.1016/j.celrep.2017.05.093?ref=journal.ninthheaven.co)
7. Ashraf, K. U., Nygaard, R., Vickery, O. N., Erramilli, S. K., Herrera, C. M., McConville, T. H., Petrou, V. I., Giacometti, S. I., Dufrisne, M. B., Nosol, K., Zinkle, A. P., Graham, C. L. B., Loukeris, M., Kloss, B., Skorupinska-Tudek, K., Swiezewska, K., Roper, D. I., Clarke, O. B., Uhlemann, A. C., Kossiakoff, A. A., ... Mancia, F. (2022). Structural basis of lipopolysaccharide maturation by the O-antigen ligase. *Nature, 604*(7905), 371–376\. [https://doi.org/10.1038/s41586-022-04555-x](https://doi.org/10.1038/s41586-022-04555-x?ref=journal.ninthheaven.co)
8. Babinski, K. J., Kanjilal, S. J., & Raetz, C. R. H. (2002). Accumulation of the lipid A precursor UDP-2,3-diacylglucosamine in an *Escherichia coli* mutant lacking the *lpxH* gene. *The Journal of Biological Chemistry, 277*(29), 25947–25956\. [https://doi.org/10.1074/jbc.M204068200](https://doi.org/10.1074/jbc.M204068200?ref=journal.ninthheaven.co)
9. Bassett, E. J., Keith, M. S., Armelagos, G. J., Martin, D. L., & Villanueva, A. R. (1980). Tetracycline-labeled human bone from ancient Sudanese Nubia (A.D. 350). *Science, 209*(4464), 1532–1534\. [https://doi.org/10.1126/science.7001623](https://doi.org/10.1126/science.7001623?ref=journal.ninthheaven.co)
10. Beutler, B. (2000). TLR4: Central component of the sole mammalian LPS sensor. *Current Opinion in Immunology, 12*(1), 20–26\. [https://doi.org/10.1016/S0952-7915(99)00046-1](https://doi.org/10.1016/S0952-7915%2899%2900046-1?ref=journal.ninthheaven.co)
11. Dowhan, W. (2011). The Raetz pathway for lipid A biosynthesis: Christian Rudolf Hubert Raetz, MD, PhD, 1946–2011\. *Journal of Lipid Research, 52*(11), 1857–1860\. [https://doi.org/10.1194/jlr.e020701](https://doi.org/10.1194/jlr.e020701?ref=journal.ninthheaven.co)
12. Hummels, K. R. (2025). The regulation of lipid A biosynthesis. *The Journal of Biological Chemistry, 301*(9), Article 110556\. [https://doi.org/10.1016/j.jbc.2025.110556](https://doi.org/10.1016/j.jbc.2025.110556?ref=journal.ninthheaven.co)
13. Janeway, C. A., Jr. (1989). Approaching the asymptote? Evolution and revolution in immunology. *Cold Spring Harbor Symposia on Quantitative Biology, 54*(Pt. 1), 1–13\. [https://doi.org/10.1101/sqb.1989.054.01.003](https://doi.org/10.1101/sqb.1989.054.01.003?ref=journal.ninthheaven.co)
14. Kumar Pal, S., & Kumar, S. (2023). LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase) inhibitors: A long path explored for potent drug design. *International Journal of Biological Macromolecules, 234*, Article 122960\. [https://doi.org/10.1016/j.ijbiomac.2022.12.179](https://doi.org/10.1016/j.ijbiomac.2022.12.179?ref=journal.ninthheaven.co)
15. Miyake, K., Ogata, H., Nagai, Y., Akashi, S., & Kimoto, M. (2000). Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1\. *Journal of Endotoxin Research, 6*(5), 389–391\. [https://doi.org/10.1177/09680519000060051001](https://doi.org/10.1177/09680519000060051001?ref=journal.ninthheaven.co)
16. Nagai, Y., et al. (2002). Essential role of MD-2 in LPS responsiveness and TLR4 distribution. *Nature Immunology, 3*(7), 667–672\. [https://doi.org/10.1038/ni809](https://doi.org/10.1038/ni809?ref=journal.ninthheaven.co)
17. Raetz, C. R., Garrett, T. A., Reynolds, C. M., Shaw, W. A., Moore, J. D., Smith, D. C., Jr., Ribeiro, A. A., Murphy, R. C., Ulevitch, R. J., Fearns, C., Reichart, D., Glass, C. K., Benner, C., Subramaniam, S., Harkewicz, R., Bowers-Gentry, R. C., Buczynski, M. W., Cooper, J. A., Deems, R. A., & Dennis, E. A. (2006). Kdo2-lipid A of *Escherichia coli*, a defined endotoxin that activates macrophages via TLR-4\. *Journal of Lipid Research, 47*(5), 1097–1111\. [https://doi.org/10.1194/jlr.M600027-JLR200](https://doi.org/10.1194/jlr.M600027-JLR200?ref=journal.ninthheaven.co)
18. Reynolds, C. M., & Raetz, C. R. (2009). Replacement of lipopolysaccharide with free lipid A molecules in *Escherichia coli* mutants lacking all core sugars. *Biochemistry, 48*(40), 9627–9640\. [https://doi.org/10.1021/bi901391g](https://doi.org/10.1021/bi901391g?ref=journal.ninthheaven.co)
19. Samuel, G., & Reeves, P. (2003). Biosynthesis of O-antigens: Genes and pathways involved in nucleotide sugar precursor synthesis and O-antigen assembly. *Carbohydrate Research, 338*(23), 2503–2519\. [https://doi.org/10.1016/j.carres.2003.07.009](https://doi.org/10.1016/j.carres.2003.07.009?ref=journal.ninthheaven.co)
20. Shimazu, R., et al. (1999). MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4\. *The Journal of Experimental Medicine, 189*(11), 1777–1782\. [https://doi.org/10.1084/jem.189.11.1777](https://doi.org/10.1084/jem.189.11.1777?ref=journal.ninthheaven.co)
21. Souza, P. F. N., Filho, N. S. D. S., Mororó, J. L. T., Brito, D. M. D. S., da Lima, A. B., Mesquita, F. P., & Montenegro, R. C. (2025). Pandemic events caused by bacteria throughout human history and the risks of antimicrobial resistance today. *Microorganisms, 13*(2), Article 457\. [https://doi.org/10.3390/microorganisms13020457](https://doi.org/10.3390/microorganisms13020457?ref=journal.ninthheaven.co)
22. Steimle, A., Autenrieth, I. B., & Frick, J. S. (2016). Structure and function: Lipid A modifications in commensals and pathogens. *International Journal of Medical Microbiology, 306*(5), 290–301\. [https://doi.org/10.1016/j.ijmm.2016.03.001](https://doi.org/10.1016/j.ijmm.2016.03.001?ref=journal.ninthheaven.co)
23. Tang, X., Tay, A., Benghezal, M., Marshall, B. J., Tang, H., & Li, H. (2025). Advances in *Helicobacter pylori* lipopolysaccharide structure and function. *FEMS Microbiology Reviews, 49*, Article fuaf034\. [https://doi.org/10.1093/femsre/fuaf034](https://doi.org/10.1093/femsre/fuaf034?ref=journal.ninthheaven.co)
24. Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994). Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. *The Journal of Experimental Medicine, 180*(3), 1025–1035\. [https://doi.org/10.1084/jem.180.3.1025](https://doi.org/10.1084/jem.180.3.1025?ref=journal.ninthheaven.co)
25. Wurfel, M. M., Hailman, E., & Wright, S. D. (1995). Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. *The Journal of Experimental Medicine, 181*(5), 1743–1754\. [https://doi.org/10.1084/jem.181.5.1743](https://doi.org/10.1084/jem.181.5.1743?ref=journal.ninthheaven.co)